HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Conditions
- Infection, Human Immunodeficiency Virus I
- HIV-1 Infection
Interventions
- DRUG: fosamprenavir/ritonavir
Sponsor
ViiV Healthcare
Collaborators